{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T20:11:14Z","timestamp":1778271074160,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RGPIN 250139"],"award-info":[{"award-number":["RGPIN 250139"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009192","name":"Alberta Innovates","doi-asserted-by":"publisher","award":["pGudLuc7.5"],"award-info":[{"award-number":["pGudLuc7.5"]}],"id":[{"id":"10.13039\/501100009192","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Environmental Toxicology and Pharmacology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.etap.2023.104214","type":"journal-article","created":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T21:21:11Z","timestamp":1688764871000},"page":"104214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Arsenic trioxide (ATO) up-regulates cytochrome P450 1A (CYP1A) enzymes in murine hepatoma Hepa-1c1c7 cell line"],"prefix":"10.1016","volume":"101","author":[{"given":"Mahmoud A.","family":"El-Ghiaty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed A.","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayman O.S.","family":"El-Kadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.etap.2023.104214_bib1","first-page":"75","article-title":"Arsenic trioxide-mediated oxidative stress and genotoxicity in human hepatocellular carcinoma cells","volume":"6","author":"Alarifi","year":"2013","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.etap.2023.104214_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.23243","article-title":"Mercury and methylmercury differentially modulate hepatic cytochrome P450 1A1 and 1A2 in vivo and in vitro","volume":"37","author":"Alqahtani","year":"2023","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.etap.2023.104214_bib3","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.freeradbiomed.2013.01.012","article-title":"Differential modulation of cytochrome P450 1a1 by arsenite in vivo and in vitro in C57BL\/6 mice","volume":"58","author":"Anwar-Mohamed","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.etap.2023.104214_bib4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.freeradbiomed.2013.10.810","article-title":"Methylated pentavalent arsenic metabolites are bifunctional inducers, as they induce cytochrome P450 1A1 and NAD(P)H:quinone oxidoreductase through AhR- and Nrf2-dependent mechanisms","volume":"67","author":"Anwar-Mohamed","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.etap.2023.104214_bib5","unstructured":"ATSDR, 2007. Toxicological profile for arsenic. Agency for Toxic Substances and Disease Registry, Atlanta."},{"key":"10.1016\/j.etap.2023.104214_bib6","series-title":"Arsenic and its compounds Priority substances list 1 assessment report","author":"CEPA","year":"1993"},{"key":"10.1016\/j.etap.2023.104214_bib7","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.freeradbiomed.2005.07.012","article-title":"The role of oxidative stress in the modulation of aryl hydrocarbon receptor-regulated genes by As3+, Cd2+, and Cr6+","volume":"39","author":"Elbekai","year":"2005","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.etap.2023.104214_bib8","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.toxlet.2007.05.009","article-title":"Transcriptional activation and posttranscriptional modification of Cyp1a1 by arsenite, cadmium, and chromium","volume":"172","author":"Elbekai","year":"2007","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.etap.2023.104214_bib9","first-page":"1184","article-title":"Arsenic: various species with different effects on cytochrome P450 regulation in humans","volume":"20","author":"El-Ghiaty","year":"2021","journal-title":"EXCLI J."},{"key":"10.1016\/j.etap.2023.104214_bib10","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1146\/annurev-pharmtox-051921-020936","article-title":"The duality of arsenic metabolism: impact on human health","volume":"63","author":"El-Ghiaty","year":"2023","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.etap.2023.104214_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110049","article-title":"Down-regulation of hepatic cytochromes P450 1A1 and 1A2 by arsenic trioxide (ATO) in vivo and in vitro: a role of heme oxygenase 1","volume":"364","author":"El-Ghiaty","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.etap.2023.104214_bib12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.toxlet.2017.02.012","article-title":"Down-regulation of cytochrome P450 1A1 by monomethylarsonous acid in human HepG2 cells","volume":"270","author":"Elshenawy","year":"2017","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.etap.2023.104214_bib13","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/toxsci\/kfr189","article-title":"Third-generation Ah receptor-responsive luciferase reporter plasmids: amplification of dioxin-responsive elements dramatically increases CALUX bioassay sensitivity and responsiveness","volume":"123","author":"He","year":"2011","journal-title":"Toxicol. Sci.: Off. J. Soc. Toxicol."},{"key":"10.1016\/j.etap.2023.104214_bib14","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00775-018-1537-9","article-title":"Arsenic trioxide: insights into its evolution to an anticancer agent","volume":"23","author":"Hoonjan","year":"2018","journal-title":"J. Biol. Inorg. Chem.: JBIC: a Publ. Soc. Biol. Inorg. Chem."},{"key":"10.1016\/j.etap.2023.104214_bib15","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41392-019-0062-9","article-title":"Local delivery of arsenic trioxide nanoparticles for hepatocellular carcinoma treatment","volume":"4","author":"Hu","year":"2019","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.etap.2023.104214_bib16","unstructured":"IARC,\u00a02004 Some drinking-water disinfectants and contaminants, including arsenic. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans."},{"key":"10.1016\/j.etap.2023.104214_bib17","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1124\/mol.105.011841","article-title":"Arsenite-induced aryl hydrocarbon receptor nuclear translocation results in additive induction of phase I genes and synergistic induction of phase II genes","volume":"68","author":"Kann","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.etap.2023.104214_bib18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/toxsci\/kfi282","article-title":"Regulatory mechanisms modulating the expression of cytochrome P450 1A1 gene by heavy metals","volume":"88","author":"Korashy","year":"2005","journal-title":"Toxicol. Sci.: Off. J. Soc. Toxicol."},{"key":"10.1016\/j.etap.2023.104214_bib19","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.freeradbiomed.2007.11.003","article-title":"The role of redox-sensitive transcription factors NF-kappaB and AP-1 in the modulation of the Cyp1a1 gene by mercury, lead, and copper","volume":"44","author":"Korashy","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.etap.2023.104214_bib20","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1124\/jpet.117.243246","article-title":"Novel pathways of ponatinib disposition catalyzed by CYP1A1 involving generation of potentially toxic metabolites","volume":"363","author":"Lin","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.etap.2023.104214_bib21","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods (San. Diego, Calif.)"},{"key":"10.1016\/j.etap.2023.104214_bib22","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1006\/abio.1993.1504","article-title":"A fluorescence-based protein assay for use with a microplate reader","volume":"214","author":"Lorenzen","year":"1993","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.etap.2023.104214_bib23","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.etap.2023.104214_bib24","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.apsb.2019.11.016","article-title":"New insights of CYP1A in endogenous metabolism: a focus on single nucleotide polymorphisms and diseases","volume":"10","author":"Lu","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"issue":"Suppl 2","key":"10.1016\/j.etap.2023.104214_bib25","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1634\/theoncologist.6-suppl_2-22","article-title":"Clinical trials of arsenic trioxide in hematologic and solid tumors: overview of the national cancer institute cooperative research and development studies","volume":"6","author":"Murgo","year":"2001","journal-title":"Oncologist"},{"key":"10.1016\/j.etap.2023.104214_bib26","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2174\/138920005774330666","article-title":"CYP1A1 is a major enzyme responsible for the metabolism of granisetron in human liver microsomes","volume":"6","author":"Nakamura","year":"2005","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.etap.2023.104214_bib27","series-title":"King of Poisons: A History of Arsenic","author":"Parascandola","year":"2012"},{"key":"10.1016\/j.etap.2023.104214_bib28","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00204-008-0332-8","article-title":"Inhibition and induction of human cytochrome P450 enzymes: current status","volume":"82","author":"Pelkonen","year":"2008","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.etap.2023.104214_bib29","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1124\/mol.52.4.590","article-title":"Aryl hydrocarbon receptor-dependent induction of cyp1a1 by bilirubin in mouse hepatoma hepa 1c1c7 cells","volume":"52","author":"Sinal","year":"1997","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.etap.2023.104214_bib30","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/med.21844","article-title":"Current status and future prospects of nanomedicine for arsenic trioxide delivery to solid tumors","volume":"42","author":"S\u00f6nksen","year":"2022","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.etap.2023.104214_bib31","first-page":"999","article-title":"Polycyclic aromatic hydrocarbon\/metal mixtures: effect on PAH induction of CYP1A1 in human HEPG2 cells","volume":"29","author":"Vakharia","year":"2001","journal-title":"Drug Metab. Dispos.: Biol. Fate Chem."},{"key":"10.1016\/j.etap.2023.104214_bib32","first-page":"326","article-title":"Therapeutic strategy of arsenic trioxide in the fight against cancers and other diseases","volume":"12","author":"Wang","year":"2020","journal-title":"Met.: Integr. Biometal Sci."},{"issue":"Suppl 2","key":"10.1016\/j.etap.2023.104214_bib33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1634\/theoncologist.6-suppl_2-3","article-title":"History of the development of arsenic derivatives in cancer therapy","volume":"6","author":"Waxman","year":"2001","journal-title":"oncologist"},{"key":"10.1016\/j.etap.2023.104214_bib34","first-page":"14","article-title":"Current advances of nanomedicines delivering arsenic trioxide for enhanced tumor therapy","author":"Yu","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.etap.2023.104214_bib35","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.etap.2023.104214_bib36","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3109\/03602530903286476","article-title":"Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2","volume":"42","author":"Zhou","year":"2010","journal-title":"Drug Metab. Rev."}],"container-title":["Environmental Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1382668923001564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1382668923001564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T09:56:56Z","timestamp":1761299816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1382668923001564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":36,"alternative-id":["S1382668923001564"],"URL":"https:\/\/doi.org\/10.1016\/j.etap.2023.104214","relation":{},"ISSN":["1382-6689"],"issn-type":[{"value":"1382-6689","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Arsenic trioxide (ATO) up-regulates cytochrome P450 1A (CYP1A) enzymes in murine hepatoma Hepa-1c1c7 cell line","name":"articletitle","label":"Article Title"},{"value":"Environmental Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.etap.2023.104214","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104214"}}